Co-Diagnostics, Inc.
(NASDAQ : CODX)

( )
CODX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -4.54%69.361.0%$1437.62m
BIIBBiogen, Inc. -0.55%308.391.5%$631.19m
REGNRegeneron Pharmaceuticals, Inc. 3.00%444.572.6%$540.75m
AMGNAmgen, Inc. -1.85%199.731.3%$516.67m
ILMNIllumina, Inc. 2.21%265.673.5%$404.58m
MRNAModerna, Inc. -0.88%25.930.0%$374.64m
VRTXVertex Pharmaceuticals, Inc. 0.33%224.031.9%$349.56m
ALXNAlexion Pharmaceuticals, Inc. 2.11%94.032.0%$225.36m
CODXCo-Diagnostics, Inc. -17.11%13.230.0%$205.07m
AAgilent Technologies, Inc. -0.59%76.971.6%$168.76m
EXASEXACT Sciences Corp. 0.16%80.9524.0%$163.88m
BMRNBioMarin Pharmaceutical, Inc. 0.61%90.374.3%$115.44m
SGENSeattle Genetics, Inc. 5.12%113.866.1%$111.32m
INCYIncyte Corp. -0.57%75.412.5%$109.76m
NVAXNovavax, Inc. 35.59%16.00184.0%$89.13m

Company Profile

Co-Diagnostics, Inc. is a molecular diagnostics company, which engages in the development, manufacture, and marketing of diagnostics technology. The company's products are utilized for tests that are designed using the detection and analysis of nucleic acid molecules. It also uses its proprietary technology to design tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.